GlassScriptPhysician profile
Araceli Yee
NPI 1699337048
$948.43
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $928 · 2022: $20.24.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $133.50 | 2021 | |
| Acadia Pharmaceuticals INC | $124.85 | 2021 | |
| Amneal Pharmaceuticals LLC | $99.96 | 2021 | |
| Amgen INC. | $89.98 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $69.10 | 2021 | |
| Upsher-Smith Laboratories LLC | $66.88 | 2021 | |
| Avanir Pharmaceuticals, INC. | $65.14 | 2021 | |
| Biogen, INC. | $43.19 | 2021 | |
| Lilly USA, LLC | $42.35 | 2021 | |
| Sunovion Pharmaceuticals INC. | $42.29 | 2021 | |
| Adamas Pharmaceuticals, INC. | $39.24 | 2021 | |
| Novartis Pharmaceuticals Corporation | $36.75 | 2021 | |
| Sk Life Science, INC. | $23.27 | 2021 | |
| Genzyme Corporation | $20.49 | 2021 | |
| Janssen Pharmaceuticals, INC | $20.37 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $18.17 | 2021 | |
| Arbor Pharmaceuticals, INC. | $12.90 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Araceli Yee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.